An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, CJC 1295 (no DAC) 5mg Ipamorelin 5mg Polaris Peptides